Stocks · Korea 080720 KOSDAQ

Union Korea Pharm

2,410원 +0.00% Market cap 1,924억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR—
EPS0 KRW
BPS0 KRW
ROE—
DPS0 KRW

Returns and 52-week range

1W+0.00%
1M+0.00%
3M+0.00%
6M+0.00%
1Y+0.00%
YTD+0.00%
52W high2,410원
52W low—
From 52W high+0.00%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
2022613억13억-9억2.1%
2023632억-52억-182억-8.3%
2024513억-135억-209억-26.2%
2025364억-172억-308억-47.4%
Quarterly
2024 4Q39억-78억-127억-197.5%
2025 1Q126억-18억-26억-14.1%
2025 2Q102억-29억-41억-28.5%
2025 3Q71억-99억-110억-139.0%
2025 4Q65억-26억-131억-40.9%
2026 1Q59억-16억-23억-26.6%

Company

CEO성광현
Founded1985-08-10
Fiscal year end12
Address: 강원도 원주시 문막읍 문막공단길 246

Peers in the same sector

CompanyMarket capP/EP/B1M
코오롱생명과학1,930억7.370.33+1.17%
이연제약1,903억—0.85+3.33%
영진약품1,955억—2.14-3.87%
환인제약1,893억11.880.45-2.02%
녹십자웰빙1,958억19.331.72+1.40%
종근당홀딩스1,881억4.420.28-3.47%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.